Clinical Trials Directory

Trials / Completed

CompletedNCT02912598

Lung Isolation in Thoracic Surgery - a Randomized Trial Comparing the VivaSight™ EB Endobronchial Blocker With Established Devices

Lung Isolation in Thoracic Surgery - a Comparison of the VivaSight™ EB Endobronchial Blocker With Established Devices

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Otto-von-Guericke University Magdeburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgery involving the chest cavity, particularly VATS procedures, often require one-lung ventilation. The double-lumen tube (DLT) is considered the gold standard for lung isolation with different models of bronchial blockers (BB) used in special populations and circumstances. Their routine use is impeded by prolonged placement times, frequent malpositionings and higher costs when compared to the DLT, as recently reported in a meta-analysis by Clayton-Smith et al. The VivaSight™ SL+EB as a combination of a single-lumen tube with an integrated camera and a bronchial blocker allows for endobronchial placement without the use of a fiberoptic bronchoscope. An external monitor provides continuous visualization of the tracheal carina and the position of the bronchial cuff. The purpose of this study was to evaluate the clinical performance of the VivaSight™ SL+EB when compared to a left-sided double-lumen tube and established bronchial blockers. The investigators hypothesized a reduction in time to initial lung isolation due to the simplified placement procedure compared to other bronchial blockers. Continuous intraprocedural airway visualization may allow for early detection of dislocations. Necessary repositionings may be possible without additional bronchoscopies, reducing both disruptions of ventilation and maintenance costs.

Conditions

Interventions

TypeNameDescription
DEVICEMallinckrodt™ Endobronchial Tube
DEVICEFuji Uniblocker™
DEVICEETView VivaSight™-SL+EB
DEVICECOOK© Arndt Endobronchial Blocker

Timeline

Start date
2015-01-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2016-09-23
Last updated
2016-09-23

Source: ClinicalTrials.gov record NCT02912598. Inclusion in this directory is not an endorsement.